Document is current
Any future updates will be listed below
-
Authors
Li, Colette https://orcid.org/0000-0002-7865-195X
Anand, Megha
McPheron, Garrett https://orcid.org/0000-0003-4956-5486
Stiles, Maeve https://orcid.org/0009-0009-4698-3886
Wayne, Elizabeth https://orcid.org/0000-0002-8526-9732
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (1 R35 GM142957-01)
- License Information
-
More Information
Article History
Received: 2 April 2025
Accepted: 12 September 2025
First Online: 23 October 2025
Declarations
:
: The authors have no competing interests to report.
: This research was conducted in accordance with ethical guidelines. In vitro use of cell lines modified via lentiviral transductions were used under Biological Use Authorization approval by the Institutional Biosafety Committee at Carnegie Mellon University and the University of Washington. There are no animal studies involved an no IACUC approval was needed.
: There are no human studies involved in this research.
: There are no human studies involved in this research.
